APH vs EDIT
Amphenol Corporation (APH) versus Editas Medicine Inc (EDIT) — a side-by-side from cached financials, not a winner call.
Amphenol Corporation (APH) is a electronic components company listed on US.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
Latest reported APH revenue for 2025-12-31 was $23.09B. Net income was $4.27B. Revenue was up 51.7% from 2024-12-31 to 2025-12-31. APH currently screens at market cap $170.77B and trailing P/E 39.9.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
APH currently screens at market cap $170.77B and trailing P/E 39.9. EDIT currently screens at market cap $375.2M.
Not investment advice. Open the APH and EDIT stock pages for the full models.
Not investment advice.